List view / Grid view
Outsourcing
Gilead aims to produce one million remdesivir treatment courses by 2021
A letter from the CEO of Gilead reveals how the company plans to scale up production of remdesivir in light of the COVID-19 pandemic.
Exploring data integrity guideline changes moving into 2020
European Pharmaceutical Review explores how a surge in the number of warning letters for data integrity failings have prompted regulators to publish new guidelines.
Trends in the CDMO industry for 2020
Over the past decade, the pharmaceutical industry has witnessed rapid growth in outsourcing services, driven by various factors including the growth of small molecules, increasing API complexities and the need to optimise costs. Here, Peter DeYoung shares his thoughts on the key trends he expects to see in the contract…
European Pharmaceutical Review Issue 1 2020
Within this issue are articles which investigate polyelectrolyte multilayers as drug carriers, discuss how developments in pharma impact logistics and examine how the industry can regulate heavy metals in medicinal cannabis. Other features include how to use the correct tablet tooling and trends for the CDMO sector this year.
A 360 overview of data integrity in life sciences
7 February 2020 | By OSIsoft
Trustworthiness in data is critical for operations within the pharmaceutical and life sciences industries, whether it is for compliance, operational excellence, reporting or development. Hear the latest findings from OSIsoft’s research in our on-demand webinar.
Global CRO market to reach $71.7 billion by 2024, says research
A report suggests the need for novel therapies and cost-effective R&D will drive growth for contract research organisations, especially in Asia-Pacific.
FDA announces new centre to improve compounded drug quality
A new centre has been established by the FDA that will allow the agency to improve the quality and safety of compounded drugs by providing educational programmes to outsourcing facilities.
Whitepaper: Product characterisation: reveal your molecule earlier, faster and with accuracy
Partnering for product characterisation can streamline drug development and create efficiencies in moving from concept to clinic.
Application Notes & Whitepapers 2019
Industry experts share their latest research and developments in pharma.
New report shows strong performance in the dose CMO industry
The dose CMO industry is performing strongly despite challenges of increasingly complex drug production, says a new report.
Global, award-winning insourcing
Eurofins PSS Insourcing Solutions® (PSS) employs and manages full-time scientists, managers and support staff to perform a defined scope of work at a client’s facility.
Enabling companies to bring medicines to patients in need
At Lonza Pharma & Biotech we provide contract development and manufacturing services that enable pharma and biotech companies to bring medicines to patients in need.
Guide to Outsourcing
In this Guide to Outsourcing, four companies showcase their services and highlight how they stand out from the crowd. Also included is a discussion of the opportunities that outsourcing presents.
North America leads in number of global pharma partnerships
Research has found that North America had the most strategic partnerships in the pharma industry from 2014 to 2019.